Mirati Therapeutics Eulerpool naujienos

Mirati Therapeutics Eulerpool News

Mirati Therapeutics akcijų naujienos

Mirati Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Mirati Therapeutics naujienas mes pateikiame čia.

• sausio 19 d. ·

  Seeking Alpha
  Mirati Therapeutics ticks higher amid Nasdaq delisting for sale to Bristol-Myers
• sausio 12 d. ·

  Yahoo
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• sausio 12 d. ·

  GuruFocus
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• sausio 11 d. ·

  Yahoo
  Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC
• sausio 10 d. ·

  Yahoo
  European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
• sausio 10 d. ·

  Seeking Alpha
  Mirati's Krazati gets EU conditional approval for lung cancer
• sausio 10 d. ·

  Thefly.com
  Mirati Therapeutics receives conditional authorization for KRAZATI from EC
• sausio 8 d. ·

  Seeking Alpha
  Bristol-Myers looking for smaller deals after 2023 shopping spree: report
• sausio 7 d. ·

  SeekingAlpha
  Tango Therapeutics Must Produce Its Own Data To Justify Its Valuation
• sausio 3 d. ·

  Thefly.com
  The biopharmaceuticals stocks to own in 2024, according to BofA